Here's the hot new trend in Wall Street research note titles: emoticons.
From Piper Jaffray on Thursday:
And we're having some fun with the title, but it's actually really apt!
In results reported Wednesday after the close, Vanda's...
Vanda Pharmaceuticals Inc. (Vanda)
(NASDAQ: VNDA) today announced top-line results of the Phase II proof of
concept clinical study investigating the safety and efficacy of tradipitant as
a monotherapy in the treatment of chronic pruritus in...
DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons.
Must Read: Warren Buffett's Top 10 Dividend Stocks
They might need the cash for a big personal purchase such as a new house or yacht, or...
Among Tuesday's biggest gainers, there are a few with elevated short interest.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
The biopharmaceutical company focused on developing products for the treatment of the central nervous system sports a...
NQ Mobile Inc (ADR) (NYSE: NQ) +27% - The company announced an $80 million repurchase program.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) +15% - Novartis AG announced it will make a $25 million investment in Vanda.
China Finance Online Co....
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) surged 19.06% to $14.18. The volume of Vanda Pharmaceuticals shares traded 952% higher than normal. Vanda Pharmaceuticals announced its plans to acquire rights to Phase II clinical compound from Novartis...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Vanda Pharmaceuticals (VNDA):